Jan 30 (Reuters) - Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to India’s new labour code, despite strong demand for its bundled test ...

Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

The ​country's largest diagnostics firm by revenue took up a one-time charge worth ₹30.1 crore linked to India's new labour ...

Earnings call Dr. Lal PathLabs reported Q3 FY25 revenue of ₹597 crore, up 10.7% YoY, with EBITDA margin at 25.8% and PAT up 19.3% YoY. Growth was driven by volume gains, improved mix, and Swasthfit ...

(Reuters) -Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid ...

BENGALURU (Reuters) - Dr. Lal PathLabs, India's biggest diagnostics firm by revenue, posted a higher profit for the third straight quarter on Thursday, due to more diagnostics and tests in the monsoon ...

The company's consolidated net profit rose to 967 million rupees ($11.2 million) in the three months to Dec. 31, from 813 million rupees a year earlier, but fell short of analysts' estimate of 976.9 ...